About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
We Need Overall Survival Results From Keynote 355 Now!
By
Steven Vogl
18 Videos
807 views
January 21, 2021
1 Comment
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
17:20
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Summary: "Top 5 Breast Cancer Studies Including KEYNO…
Feat.
P. Tarantino
49:07
SABCS 2022 Conference Coverage
SABCS 2022 Expert Panel Discussion: Practice-Changing Updates
Feat.
J. O'Shaughnessy,
S. Tolaney,
S. Hurvitz,
H. Rugo
22:34
Dana-Farber Cancer Institute
What's New in Breast Cancer?
Feat.
S. Tolaney
12:21
Insights from 2023 SABCS
SABCS 2023 Insights: "How to Treat TNBC"
Feat.
P. Sharma
20:42
Total Health
2022 Updates in TNBC
Feat.
I. Schlam
02:05
ecancer
ESMO 2023 Insights: "CheckMate 7FL Phase 3 Study - Nivo or Plac…
Feat.
S. Loi
07:49
ESMO Breast Cancer 2023 Congress Coverage
ESMO Breast Cancer 2023 KEYNOTE-355 Trial: Outcomes in TNBC Patients…
Feat.
H. Rugo
17:57
UChicago Medicine
Neoadjuvant & Adjuvant Therapy for High-Risk, Early Stage TNBC
Feat.
R. Nanda
35:14
OncoAlert
Advanced TNBC Updates
Feat.
H. Rugo
14:15
Insights from 2023 SABCS
SABCS 2023 Insights: "KEYLYNK-009 Study - Pembro + Olaparib vs.…
Feat.
H. Rugo
14:11
ESMO Breast Cancer 2023 Congress Coverage
ESMO Breast Cancer 2023 Highlights: Key Studies Including IMPassion0…
Feat.
P. Tarantino
12:50
Oncology Data Advisor
Expert Perspectives in the Management of TNBC
Feat.
S. Tolaney
07:50
Virginia Kaklamani
2L Therapy in mTNBC
10:22
ESMO 2022 Conference Coverage
ESMO 2022 Updates on mTNBC
Feat.
L. Carey
04:09
ecancer
Management of HER2+ mBC Treatment Algorithm
Feat.
S. Swain
02:27
Insights from 2023 SABCS
SABCS 2023 Insights: "HER2CLIMB-05 Trial - Tucatinib or Placebo…
Feat.
E. Hamilton
14:40
Erin Cobain
Neoadjuvant Chemo-IO for HR+/HER2- BC
18:08
Dana-Farber Cancer Institute
Current Treatment Options for Patients With HER2+ mBC
Feat.
N. Lin
17:18
OncoAlert
Updates on HR+ and HER2+ Advanced Breast Cancer
Feat.
E. Hamilton
17:59
2023 Evolution Conference
New Frontiers in Triple Negative Breast Cancer
Feat.
R. L. Mahtani